Medical specialists from Taiwan tagged as investigators in clinical trials studying Alopecia Areata

Total 6 results

Chao-Chun Yang
Seen in:
- Tainan, National Cheng Kung University Hospital
Trials:
- NCT05723198 (Principal Investigator)
Conditions:
Chih-Chiang Chen
Seen in:
- Taipei City, Taipei Veterans General Hospital
- Taipei, Taipei City, Taipei Veterans General Hospital
- Taipei, Taipei Veterans General Hospital
Trials:
- NCT05559359 (Principal Investigator)
- NCT05723198 (Principal Investigator)
- NCT05735483 (Principal Investigator)
- NCT05911841 (Principal Investigator)
Conditions:
Po-Ju Lai
Seen in:
- Taichung City, Chung Shan Medical University Hospital
- Taichung, Taichung City, Chung Shan Medical University Hospital
Trials:
- NCT05559359 (Principal Investigator)
- NCT05723198 (Principal Investigator)
- NCT05735483 (Principal Investigator)
- NCT05911841 (Principal Investigator)
Conditions:
Tsen-Fang Tsai
Seen in:
- Taipei, National Taiwan University Hospital
Trials:
- NCT05723198 (Principal Investigator)
Conditions:
Wen-Hung Chung
Seen in:
- Taoyuan County, Chang Gung Memorial Hospital - Taipei
- Taoyuan, Chang Gung Memorial Hospital - Taipei
Trials:
- NCT05723198 (Principal Investigator)
Conditions:
Woan-Ruoh Lee
Seen in:
- New Taipei, New Taipei City, Taipei Medical University Shuang Ho Hospital
Trials:
- NCT05723198 (Principal Investigator)
Conditions:

Clinical Trials on Alopecia Areata

Eli Lilly and Company

Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

Skin Diseases | Pathological Conditions, Anatomical | Alopecia | Hypotrichosis | Hair Diseases | Areata Alopecia

United States, Taiwan, Japan, Spain, Korea, Republic of, Germany, France, Mexico, Canada, Poland, Australia, Hungary, Argentina
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Active, not recruiting

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata (AA)

Alopecia Areata(AA)

China
University Hospital, Rouen

Completed

The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade (MP3)

ALOPECIA AREATA

France
Services Institute of Medical Sciences, Pakistan

Completed

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

Extensive Alopecia Areata

Pakistan
Yale University

Completed

Tofacitnib for the Treatment of Alopecia Areata and Variants

Alopecia Areata (AA) | Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Inmagene LLC

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Alopecia Areata (AA)

United States, Canada
Siriraj Hospital

Completed

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Recalcitrant Alopecia Totalis | Recalcitrant Alopecia Universalis

Thailand
University of Florida

Withdrawn

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Female Androgenetic Alopecia

United States
Equillium

Withdrawn

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Lindsey Bordone

Withdrawn

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Medical specialists from Taiwan tagged as investigators in clinical trials studying Alopecia Areata

Clinical Trials on Alopecia Areata

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations